PPIDT00301
Drug Information
| Name | Dibotermin alfa |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB11639 |
| Type | biotech |
| Indication | - indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation [FDA Label]. - indicated for single-level lumbar interbody spine fusion as a substitute for autogenous bone graft in adults with degenerative disc disease who have had at least 6 months of non-operative treatment for this condition [L1391]. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| — | — |
1.5 mg/ml
|
| Implant | Intracavitary |
1.5 mg/ml
|